【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 16
2 Introduction 17
2.1 Cardiovascular Surgery Devices Overview 17
3 Products under Development 19
3.1 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 19
3.2 Cardiovascular Surgery Devices – Pipeline Products by Segment 20
3.3 Cardiovascular Surgery Devices – Pipeline Products by Territory 21
3.4 Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path 23
3.5 Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date 24
3.6 Cardiovascular Surgery Devices – Ongoing Clinical Trials 25
4 Cardiovascular Surgery Devices – Pipeline Products under Development by Companies 26
4.1 Cardiovascular Surgery Devices Companies – Pipeline Products by Stage of Development 26
4.2 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 30
5 Cardiovascular Surgery Devices Companies and Product Overview 34
5.1 3S BioMedical, Inc. Company Overview 34
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.2 AblaCor Medical Corporation Company Overview 35
5.2.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 Advanced Catheter Therapies, Inc. Company Overview 36
5.3.1 Advanced Catheter Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 AdvanSource Biomaterials Corporation Company Overview 38
5.4.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.5 AFreeze GmbH Company Overview 42
5.5.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
5.6 Anethon (Inactive) Company Overview 47
5.6.1 Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47
5.7 AngioDynamics, Inc. Company Overview 48
5.7.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Apaxis Medical, Inc. Company Overview 51
5.8.1 Apaxis Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.9 APK Advanced Medical Technologies, Inc. Company Overview 55
5.9.1 APK Advanced Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.10 Arterion AB Company Overview 56
5.10.1 Arterion AB Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 AtriCure, Inc. Company Overview 57
5.11.1 AtriCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.12 Axcelon Biopolymers Corp. Company Overview 61
5.12.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Beth Israel Deaconess Medical Center, Inc. Company Overview 62
5.13.1 Beth Israel Deaconess Medical Center, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Bioretec Ltd. Company Overview 64
5.14.1 Bioretec Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.15 Boston University Company Overview 65
5.15.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 65
5.16 CardioPolymers, Inc. Company Overview 67
5.16.1 CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.17 CardioPrecision Ltd Company Overview 68
5.17.1 CardioPrecision Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 CardioScout, LLC Company Overview 69
5.18.1 CardioScout, LLC Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 CellProthera Company Overview 70
5.19.1 CellProthera Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 Children’s Hospital Boston Company Overview 72
5.20.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 72
5.21 Circulatory Technology Inc. Company Overview 74
5.21.1 Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.22 Cleveland Clinic Hospital Company Overview 75
5.22.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 75
5.23 Corazon Technologies, Inc. Company Overview 77
5.23.1 Corazon Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.24 CorMatrix Cardiovascular, Inc. Company Overview 78
5.24.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.25 Coromedic Ltd. Company Overview 81
5.25.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
5.26 CPSI Biotech Company Overview 83
5.26.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
5.27 Cytograft Tissue Engineering, Inc. Company Overview 84
5.27.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Design Mentor, Inc. Company Overview 88
5.28.1 Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.29 Edwards Lifesciences Corporation Company Overview 89
5.29.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 89
5.30 Elana bv Company Overview 91
5.30.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 91
5.31 Emory University Company Overview 92
5.31.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 92
5.32 Endogene Ltd Company Overview 94
5.32.1 Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.33 EpiEP, Inc. Company Overview 97
5.33.1 EpiEP, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.34 European Medical Contract Manufacturing B.V. Company Overview 98
5.34.1 European Medical Contract Manufacturing B.V. Pipeline Products & Ongoing Clinical Trials Overview 98
5.35 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V. Company Overview 99
5.35.1 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V. Pipeline Products & Ongoing Clinical Trials Overview 99
5.36 Graft-Loc Inc. Company Overview 100
5.36.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.37 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 101
5.37.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
5.38 Harpoon Medical, Inc. Company Overview 103
5.38.1 Harpoon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.39 HeartLander Surgical, Inc. Company Overview 106
5.39.1 HeartLander Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.40 Helical Solutions, Inc. Company Overview 107
5.40.1 Helical Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.41 Hocor Cardiovascular Technologies, LLC Company Overview 108
5.41.1 Hocor Cardiovascular Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 108
5.42 iiTech BV Company Overview 109
5.42.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 109
5.43 Kardium Inc. Company Overview 112
5.43.1 Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview 112
5.44 Kips Bay Medical, Inc. Company Overview 116
5.44.1 Kips Bay Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.45 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 118
5.45.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 118
5.46 LivaNova PLC Company Overview 119
5.46.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 119
5.47 LuxCath, LLC Company Overview 126
5.47.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 126
5.48 Magenta Medical Inc Company Overview 127
5.48.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 127
5.49 Mayo Clinic. Company Overview 128
5.49.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 128
5.50 MedArray Inc. Company Overview 129
5.50.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
5.51 Medrobotics Corporation Company Overview 132
5.51.1 Medrobotics Corporation Pipeline Products & Ongoing Clinical Trials Overview 132
5.52 Medtronic plc Company Overview 134
5.52.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 134
5.53 Michigan Critical Care Consultants, Inc. Company Overview 136
5.53.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.54 MicroPort Scientific Corporation Company Overview 137
5.54.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 137
5.55 Neograft Technologies, Inc. Company Overview 139
5.55.1 Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 139
5.56 Nipro Corporation Company Overview 142
5.56.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 142
5.57 Northwestern University Company Overview 145
5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 145
5.58 NovelMed Therapeutics, Inc. Company Overview 148
5.58.1 NovelMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 148
5.59 Novogate Medical Ltd. Company Overview 149
5.59.1 Novogate Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 149
5.60 NuPulse Inc Company Overview 150
5.60.1 NuPulse Inc Pipeline Products & Ongoing Clinical Trials Overview 150
5.61 NuVascular Technologies Inc Company Overview 151
5.61.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 151
5.62 Prekubator TTO Company Overview 152
5.62.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 152
5.63 Protego Medical Pty Ltd Company Overview 153
5.63.1 Protego Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 153
5.64 Rafael Medical Technologies, Inc. Company Overview 154
5.64.1 Rafael Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 154
5.65 Replication Medical, Inc. Company Overview 155
5.65.1 Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 155
5.66 Revivicor, Inc. Company Overview 157
5.66.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.67 SeamVad Ltd. Company Overview 158
5.67.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 158
5.68 SentreHEART, Inc. Company Overview 160
5.68.1 SentreHEART, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.69 Sorin S.p.A. (Inactive) Company Overview 163
5.69.1 Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 163
5.70 Southern Research Institute Company Overview 166
5.70.1 Southern Research Institute Pipeline Products & Ongoing Clinical Trials Overview 166
5.71 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 167
5.71.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 167
5.72 St. Jude Medical, Inc. Company Overview 171
5.72.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.73 Stanford University Company Overview 173
5.73.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 173
5.74 Synovis Life Technologies, Inc. Company Overview 175
5.74.1 Synovis Life Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 175
5.75 Tengion, Inc. (Inactive) Company Overview 176
5.75.1 Tengion, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 176
5.76 The Johns Hopkins University Company Overview 178
5.76.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 178
5.77 The Spectranetics Corporation Company Overview 180
5.77.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 180
5.78 The University of Utah Company Overview 182
5.78.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 182
5.79 Theracardia Company Overview 184
5.79.1 Theracardia Pipeline Products & Ongoing Clinical Trials Overview 184
5.80 Thermedical, Inc. Company Overview 185
5.80.1 Thermedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
5.81 Tissue Regeneration Technologies, LLC Company Overview 187
5.81.1 Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 187
5.82 Trivitron Healthcare Pvt Ltd. Company Overview 189
5.82.1 Trivitron Healthcare Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview 189
5.83 Tufts Medical Center Company Overview 190
5.83.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 190
5.84 Universite de Montreal Company Overview 191
5.84.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 191
5.85 University College London Company Overview 193
5.85.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 University of Arizona Company Overview 194
5.86.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 University of California, Los Angeles Company Overview 196
5.87.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 196
5.88 University of Nebraska Company Overview 199
5.88.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 199
5.89 University of Pittsburgh Company Overview 200
5.89.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 200
5.90 University of Strathclyde Company Overview 202
5.90.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 202
5.91 Vanderbilt University Company Overview 203
5.91.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 203
5.92 Veniti, Inc. Company Overview 205
5.92.1 Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.93 Ventrica, Inc. Company Overview 206
5.93.1 Ventrica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 206
5.94 VytronUS, Inc. Company Overview 207
5.94.1 VytronUS, Inc. Pipeline Products & Ongoing Clinical Trials Overview 207
5.95 W-Z BIOTECH, LLC Company Overview 208
5.95.1 W-Z BIOTECH, LLC Pipeline Products & Ongoing Clinical Trials Overview 208
6 Cardiovascular Surgery Devices- Recent Developments 210
7 Appendix 339
7.1 Methodology 339
7.2 About GlobalData 341
7.3 Contact Us 342
7.4 Disclaimer 342
【レポート販売概要】
■ タイトル：世界の心血管手術機器開発動向：医療機器パイプライン分析2015■ 英文：Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0141EPD
■ 調査対象地域：グローバル
- アンドロイド端末データベース：ベンダー別、モデル別、地域別ユーザー数（Android Devices Database: Activations by Vendor, Handset Model & Region Q1'2012）While Android growth is slowing down, the Google backed operating system still maintained triple figure Year-on-Year (YoY) growth of + 126 % in Q1’2012. With nearly 85 million shipments in Q1’2012, Android Smartphones maintained market domination within the Smartphone segment of the market, with a global market share of 59 % and increasing the installed base of legitimate Android device (handset) …
- スコットランドの再生可能エネルギー産業分析：Analyzing Renewable Energy Industry in ScotlandScotland is utilizing its abundant renewable resources to the greatest potential. Scotland is known across the world for its beautiful landscapes and dynamic renewable energy industry and the Scottish Government has to balance both of these priorities. The oil, gas and renewable energy sectors make a significant contribution to the Scottish economy and provide substantial opportunities for investm …
- 世界のパスタ・麺市場動向（2014年4月）：ニュース・イベントSynopsis Using this report, marketers will effectively gain an insight into the latest happenings in the global pasta & noodles market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global pasta & noodles market on a monthly basis. Scope The report provides a review of the latest news and key events in t …
- マイクロPLC及びナノPLCの世界市場予測（～2022年）The micro and nano PLC market is expected to reach USD 8.89 Billion by 2022, at a CAGR of 6.9% between 2016 and 2022. The growth of this market is propelled by the growing industrial automation, requirement for compact automation solutions, and growing home and building automation market. Micro PLC is expected to hold a large share of the overall micro and nano PLC market in 2016. Micro PLC offers …
- 個包装スープの世界市場2016-2020：電子レンジ調理用スープ、レディ・トゥ・ドリンクスープAbout Packaged Soups The global packaged soups market is driven by various factors such as increasing strategic partnerships in the market, investments by major players in start-ups, and due to new product introductions. There are also various trends emerging in the market, which are expected to affect the market during the forecast period. Technavio’s analysts forecast the global packaged soups m …
- 航空機衝突防止装置（ACAS）の世界市場予測（～2022年）“The airborne collision avoidance system market is projected to grow at a CAGR of 5.68% from 2017 to 2022”The airborne collision avoidance system market is projected to grow from an estimated USD 6.04 billion in 2017 to USD 7.97 billion by 2022, at a CAGR of 5.68% from 2017 to 2022. Regulatory mandates for the installation of ACAS II, rise in the number of UAVs in the commercial airspace, and rise …
- 不妊治療の世界市場2018-2022About Infertility Treatment Infertility is a medical condition, observed in both men and women. It is the inability of a person to reproduce naturally. The global infertility treatment market involves the various drugs, devices, and services provided to treat infertility. Technavio’s analysts forecast the global infertility treatment market to grow at a CAGR of 5.23% during the period 2018-2022. C …
- 菜食主義向け包装食品の世界市場2016-2020About Packaged Vegan Foods Consumers adopting veganism as a way of life and those who are focusing on cutting down on animal-based dairy products prefer packaged vegan foods. Along with this, the health benefits associated with the consumption of vegan foods will predominantly driving the market demand during the forecast period. Packaged vegan foods are prepared without the use of any animal-base …
- 世界のGaN系LEDパッケージ市場About Packaged GaN LED Packaged GaN LEDs are a type of LEDs that have an encapsulation made of an optical lens, bonding wire, electrode, and resin. Packaged GaN LEDs were invented in Japan by Nichia in 1993 and were made available in the market in the late 1990s. These LEDs are widely used for general lighting applications in residential complexes, offices, retail stores, hospitals, and industries …
- 流量計の世界市場：アナログ流量計、スマート流量計About the Flow Meter Market Flow meters measure the mass, quantity, pressure and velocity of any fluid or gas flowing through a pipeline. These meters are classified into two types: • Analog flow meters • Smart/intelligent flow meters At present, the majority of the flow meters used are traditional analog flow meters, which are used to measure the flow of the fluid (oil and water) and gas (LPG, NG …
- 心臓発作：治療薬のグローバル治験動向（2014年下半期）Heart Attack Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Heart Attack Global Clinical Trials Review, H2, 2014" provides data on the Heart Attack clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Attack. It includes an overview of the trial numbers and their recruitment status as per the sit …
- ロシアの心臓血管外科用機器市場見通し（～2021）Russia Cardiovascular Surgery Outlook to 2021 Summary GlobalData’s new report, "Russia Cardiovascular Surgery Outlook to 2021", provides key procedures data on the Russia Cardiovascular Surgery. The report provides procedure volumes within market segments - Coronary Artery Bypass Graft (CABG) Procedures and Isolated Valve Procedures. The data in the report is derived from dynamic market forecast m …
- スマートビルディングの世界市場：インテリジェントセキュリティシステム、エネルギー管理、インフラ管理The smart building market size is estimated to grow from USD 5.73 Billion in 2016 and to USD 24.73 Billion by 2021, at a CAGR of 34.0% from 2016 to 2021. Some of the major factors that are driving the growth of the market include the growing government initiatives for the development of smart building projects, rising focus on green buildings, and evolution of building management IoT platforms. Fu …
- がん医療におけるゲノミクスの世界市場分析：製品別（機器、消耗品、サービス）、用途別（診断、個別化医療、薬の発見･開発、研究）、技術別（ゲノム配列決定、PCR、マイクロアレイ、核酸抽出および精製）、エンドユーザー別（病院、研究機関、学術機関）、セグメント予測Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accura …
- ドラッグデリバリー技術市場（2014-2024）Drug Delivery Technologies - new study showing you trends, R&D progress, and predicted revenues Where is the drug delivery technologies market heading? What are the commercial prospects for this market and related technologies? Visiongain’s new report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects. Our 202 page report provides 157 tables, charts …
